Controlled Substance Monitoring & Legislative updates

Slides:



Advertisements
Similar presentations
Chapter 17: Institutional Pharmacy Jeffery D. Evans, Pharm.D. Associate Professor of Pharmacy Practice.
Advertisements

Preventing Prescription Drug Abuse: Laws and Legislation Hollie Hendrikson, MSc Policy Specialist, Health Program.
Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015.
CDER/CSS ALSDAC September 9-10, 2003 Risk Management and the Controlled Substances Act: The FDA Perspective Deborah B. Leiderman, M.D., M.A. Director Controlled.
Dispensing Controlled Substances Pharmacy 151 Introduction to Pharmacy Law.
VIRGINIA PRESCRIPTION MONITORING PROGRAM C.A.R.E Presentation February 27, 2015 Ralph Orr Director, Virginia Prescription Monitoring Program.
Pharmacy Department Overview & Prescription Regulations
Medication History: Keeping our patients safe. How do we get all of the correct details?
Preparing your data base for Medication Reconciliation.
Prescription Module in AxiUm (for prescription and OTC medications) at the USC School of Dentistry 2005 Marina Lazzara-Jimenez, RDH Director of Quality.
Chapter 6 Dispensing Medications in the Community Pharmacy
Certificate of Public Need in Other States
Coordinator University Clinical Research Pharmacy Investigational Drug Service (IDS) Marjorie Shaw Phillips, MS, RPh, FASHP Clinical Research Pharmacist.
Maryland Cancer Plan Pain Management Committee Suzanne A Nesbit, PharmD, BCPS Clinical Coordinator, Cancer Pain Service Sidney Kimmel Comprehensive Cancer.
California State Board of Pharmacy Continuing Education Program Senate Bill 151 (Burton)
Richard Z Aramini, PharmD PGY-1 Pharmacy Practice Resident Bay Pines VA Healthcare Center.
Kara Jackson Clinical Pharmacy Technician Minneapolis, MN.
Prescription Drug Monitoring Programs: Analysis of State Level Usage Requirements Matthew Penn, JD, Carla Chen, JD Director, Public Health Law Program.
Dispensing to in and out patients or Drug distribution system
Pharmacy Administrator: Manager / Adminstrator for Pharmacies Research Leader for: oUoUniversities oHoHealth Insurance oPoPharmaceutical Companies.
ACCESS TO MEDICINES - POLICY AND ISSUES
2015 Tennessee Controlled Substances Monitoring Database Program D. Todd Bess, Pharm.D. Director Tennessee Controlled Substance Monitoring Database.
Study Finds Persons Who Fill Buprenorphine Prescriptions Have Higher Rates of Medical Conditions Associated with Pain and Comorbid Psychiatric Disorders.
November 2, 2005 (Afternoon Revision) San Diego, California1.
PHASE I WRAP-UP Day 1 – 10:00a PHASE I WRAP-UP -- Rangeland Burning on Private Lands – Technical Approach and EI Development.
LECTURE FOR ASSIGNMENT 1 AND 2
Rachelle S. Mercier, Esq., MPH November 6, PMP – What is it? A system that records schedule II-V medications that patients have been prescribed.
Table of Contents.  Legal and Safety Issues Go Go  Prescriptions and Abbreviations Go Go.
Pharmacist Red Flags and the Idaho PMP Marcus C. Hurst, PharmD Retail Pharmacist Albertson’s/Save-On March 5 th, 2016.
Erin Herzig Valley Medical Group Opioid Education and Awareness Task Force.
SCRIPTS South Carolina Reporting & Identification Prescription Tracking System.
Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Pennsylvania's Prescription Drug Monitoring Program (PDMP) May 17, 2016.
The Prescription The pharmacy technician is often the first person to examine the patient’s prescription for completeness and other issues. Due to this.
Incidental Medical Services (IMS) Department of
Inventory Management Chapter 13.
Assisting the pharmacist
Expanded State Agency Use of NMLS
Supplementary Data Tables, Utilization and Volume
Table 3.1: Trends in Inpatient Utilization in Community Hospitals, 1992 – 2012
HEDIS ® Measures & Tips: Behavioral Health
Table 3.1: Trends in Inpatient Utilization in Community Hospitals, 1987 – 2007
OPIOID SAFETY. Indiana Statistics In Summary… About 100 Hoosiers die from drug overdoses every month, many from opioids such as heroin and prescription.
CHAPTER 4 Information Management in Pharmacy.
The Prescription The pharmacy technician is often the first person to examine the patient’s prescription for completeness and other issues. Due to this.
PMP Advisory Committee
An Overview of the ePDMP
Utah’s APCD as a Stand-alone Opioid Monitoring Tool
PMP Advisory Committee
Complete a legally valid prescription.
Medication order entry & Fill process
Federal Regulations requirements for opioid prescription course
Barbara Allison-Bryan, MD
Controlled Substance Utilization Review and Evaluation System
Prescription Drug Monitoring Program
Chapter 5 Prescriptions.
Prescription Drug Monitoring Program
Controlled Substances
Utilizing Data for Research
Controlled Substances
Prescription Drug Monitoring Program
National Credentialing Forum 2019 San Diego, CA February
Illinois Prescription Monitoring Program
Updating Pharmacy Information on the Home Med List and on the Discharge Reconciliation In addition to collecting the home medications, you will now be.
State of Biosimilars Legislation
PMP Advisory Committee
Preventing Medication Errors
Expanded State Agency Use of NMLS
Controlled Substances
Data Sources ADH: Other AR Data: National: Vital Statistics PDMP
Presentation transcript:

Controlled Substance Monitoring & Legislative updates Anthony may, pharmd. Mba Pharmacy supervisor

CSD.UTAH.GOV

The CSD will not contain information from the following CSD.UTAH.GOV Utah CSD collects data on CII-V drugs from all retail and outpatient hospital pharmacies as well as in and out of state mail order pharmacies. The CSD will not contain information from the following Federal Facilities* Pharmacies Licensed in other states Medications administered inpatient Access is available to prescribing practitioners and pharmacists as well as assigned designees

CSD.UTAH.GOV

Individual Search

Advanced Search

Birthdate is required, name is not Search Tips: Birthdate is required, name is not If interested in data for a different state that must be selected Date range defaults to 1 year but can be adjusted to 6 months, 1, 3 or 5 year Advanced search allows to you to also search by address and +/- years on birthdate

Out of State Patients Idaho New Mexico Mississippi Nevada North Dakota Colorado South Carolina Kansas Arizona

Search Results

Search Results

Search Results Patient fill records come up from the past year Note that the patient fills clonazepam and oxycodone, yet the active benzos and opioids tab is not highlighted DOPL now shows date sold, not date filled Select “Detailed Report” for pharmacy information

Search Results

Provider Search

Wyoming Patients

Integration into Practice

QUESTIONS?

Utah H.B 50 – Opioid Prescribing Regulations 58-37f-304. Database utilization. (2)(b) A prescriber shall check the database for information about a patient before the first time the prescriber gives a prescription to a patient for a Schedule II opioid or a Schedule III opioid (2)(c) A prescriber is not required to check the database under Subsection (2)(b) if: (i) the prescription for a Schedule II opioid or a Schedule III opioid is for three days or <           (ii) the prescriber has prior knowledge of the patient's prescription history based on the       prescriber's review of the patient's health record           (iii) the prescription for a Schedule II opioid or a Schedule III opioid is a post surgical      prescription and the total duration of opioid written after the surgery has been for 30 days or fewer.

Utah H.B 50 – Opioid Prescribing Regulations “A prescription for a Schedule II or Schedule III controlled substance that is an opiate and that is issued for an acute condition shall be completely or partially filled in a quantity not to exceed a seven-day supply as directed on the daily dosage rate of the prescription”

Utah H.B 50 – Opioid Prescribing Regulations Exceptions: Does not apply to a prescription issued for a surgery when the practitioner determined that a quantity exceeding seven days is needed Does not apply to prescriptions issued for complex or chronic conditions which are documented as being complex or chronic in the medical record A pharmacist is not required to verify that a prescription is in compliance with subsection (7)(f)(iii).